Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Combier

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Rheumatology (Oxford, England)|March 24, 2023
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospitalSophie Hecquet, Alice Combier, Alexia Steelandt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2024
Changes in Descending Pain Modulation During Anti-Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and SpondyloarthritisAnne-Priscille Trouvin, Arielle Simunek, Joël Coste, et al.
The Journal of Rheumatology|June 15, 2022
Evaluation of Patients With Rheumatoid Arthritis in Teleconsultation During the First Wave of the COVID-19 PandemicJérôme Avouac, Anna Molto, Camélia Frantz, et al.
Clinical Rheumatology|June 4, 2026
Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational studySalomé Abdellaoui, Omar Al Tabaa, Stéphane Hilliquin, et al.
Seminars in Arthritis and Rheumatism|November 7, 2024
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritisOmar Al Tabaa, Sophie Hecquet, Marion Thomas, et al.
Rheumatology (Oxford, England)|October 4, 2023
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?Roba Ghossan, Omar Al Tabaa, Alice Combier, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|April 13, 2021
Alice Combier, Sarah Wanono, Lucile Poiroux, et al.
Joint Bone Spine|July 23, 2023
Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practicePaola Vidal-Montal, Marion Thomas, Alice Combier, et al.
Rheumatology (Oxford, England)|November 2, 2021
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patientsJérôme Avouac, Corinne Miceli-Richard, Alice Combier, et al.
Annals of the Rheumatic Diseases|August 12, 2024
SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastaseAugustin Latourte, Sarah Jaulerry, Alice Combier, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|March 24, 2023
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospitalSophie Hecquet, Alice Combier, Alexia Steelandt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2024
Changes in Descending Pain Modulation During Anti-Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and SpondyloarthritisAnne-Priscille Trouvin, Arielle Simunek, Joël Coste, et al.
The Journal of Rheumatology|June 15, 2022
Evaluation of Patients With Rheumatoid Arthritis in Teleconsultation During the First Wave of the COVID-19 PandemicJérôme Avouac, Anna Molto, Camélia Frantz, et al.
Clinical Rheumatology|June 4, 2026
Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational studySalomé Abdellaoui, Omar Al Tabaa, Stéphane Hilliquin, et al.
Seminars in Arthritis and Rheumatism|November 7, 2024
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritisOmar Al Tabaa, Sophie Hecquet, Marion Thomas, et al.
Rheumatology (Oxford, England)|October 4, 2023
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?Roba Ghossan, Omar Al Tabaa, Alice Combier, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|April 13, 2021
Alice Combier, Sarah Wanono, Lucile Poiroux, et al.
Joint Bone Spine|July 23, 2023
Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practicePaola Vidal-Montal, Marion Thomas, Alice Combier, et al.
Rheumatology (Oxford, England)|November 2, 2021
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patientsJérôme Avouac, Corinne Miceli-Richard, Alice Combier, et al.
Annals of the Rheumatic Diseases|August 12, 2024
SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastaseAugustin Latourte, Sarah Jaulerry, Alice Combier, et al.
Pageof 3